GB9513508D0 - Quinazoline derivatives - Google Patents
Quinazoline derivativesInfo
- Publication number
- GB9513508D0 GB9513508D0 GBGB9513508.3A GB9513508A GB9513508D0 GB 9513508 D0 GB9513508 D0 GB 9513508D0 GB 9513508 A GB9513508 A GB 9513508A GB 9513508 D0 GB9513508 D0 GB 9513508D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- quinazoline derivatives
- quinazoline
- derivatives
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/95—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
- C07D239/96—Two oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Immunology (AREA)
- Obesity (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pain & Pain Management (AREA)
- Neurology (AREA)
- Nutrition Science (AREA)
- Biomedical Technology (AREA)
- Cardiology (AREA)
- Neurosurgery (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pulmonology (AREA)
- Heart & Thoracic Surgery (AREA)
- Transplantation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9513508.3A GB9513508D0 (en) | 1995-07-03 | 1995-07-03 | Quinazoline derivatives |
AU62437/96A AU6243796A (en) | 1995-07-03 | 1996-07-01 | Quinazoline derivatives |
JP9504991A JPH11508588A (en) | 1995-07-03 | 1996-07-01 | Quinazoline derivatives |
PCT/JP1996/001825 WO1997002254A1 (en) | 1995-07-03 | 1996-07-01 | Quinazoline derivatives |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9513508.3A GB9513508D0 (en) | 1995-07-03 | 1995-07-03 | Quinazoline derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
GB9513508D0 true GB9513508D0 (en) | 1995-09-06 |
Family
ID=10777048
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB9513508.3A Pending GB9513508D0 (en) | 1995-07-03 | 1995-07-03 | Quinazoline derivatives |
Country Status (4)
Country | Link |
---|---|
JP (1) | JPH11508588A (en) |
AU (1) | AU6243796A (en) |
GB (1) | GB9513508D0 (en) |
WO (1) | WO1997002254A1 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997024335A1 (en) * | 1995-12-28 | 1997-07-10 | Fuji Chemical Industry Co., Ltd. | Process for the preparation of 3-dihalobenzyl-2,4-quinazolinedione derivatives |
EP1510519B1 (en) * | 1997-09-05 | 2006-02-15 | Glaxo Group Limited | Pharmaceutical compositions comprising 2,3-diarylpyrazolo[1,5-B]pyridazine derivatives |
DE10056312A1 (en) | 2000-11-14 | 2002-05-16 | Bayer Ag | New 1-(N-substituted amidoalkyl) bicyclic uracil derivatives useful as medicaments for treating ischemia or reperfusion damage, are poly-(ADP-ribose)-synthetase inhibitors |
US10016425B2 (en) | 2016-11-03 | 2018-07-10 | King Saud University | Anti-ulcerative colitis compound |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3172006D1 (en) * | 1980-05-22 | 1985-10-03 | Masayuki Ishikawa | Novel quinazoline-dione compounds, process for production thereof and pharmaceutical use thereof |
-
1995
- 1995-07-03 GB GBGB9513508.3A patent/GB9513508D0/en active Pending
-
1996
- 1996-07-01 AU AU62437/96A patent/AU6243796A/en not_active Abandoned
- 1996-07-01 WO PCT/JP1996/001825 patent/WO1997002254A1/en active Application Filing
- 1996-07-01 JP JP9504991A patent/JPH11508588A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
JPH11508588A (en) | 1999-07-27 |
AU6243796A (en) | 1997-02-05 |
WO1997002254A1 (en) | 1997-01-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EG24134A (en) | Quinazoline derivatives | |
SG43262A1 (en) | Quinazoline derivatives | |
GB9508537D0 (en) | Quinazoline derivatives | |
GB9508535D0 (en) | Quinazoline derivative | |
IL112673A0 (en) | Quinazoline derivatives | |
AU5343096A (en) | Quinazoline derivatives | |
GB9607729D0 (en) | Quinazoline derivatives | |
HU9700344D0 (en) | Substituted quinazoline derivatives | |
ZA9610725B (en) | Tyrosine derivatives | |
GB2306473A8 (en) | Glucoxide derivatives | |
GR3035577T3 (en) | Benzisothiazolyl-substituted aminomethylchroman derivatives | |
GR3036572T3 (en) | 4-amino-benzoylguanidine derivatives | |
EP0754668A3 (en) | Fluorobenzylether derivatives | |
GB9516349D0 (en) | Aza-anthracyclinone derivatives | |
GB9513508D0 (en) | Quinazoline derivatives | |
GR3036344T3 (en) | 4-mercapto-benzoylguanidine derivatives | |
EP0804205A4 (en) | 4-aza-19-norandrostane derivatives | |
GB9708363D0 (en) | Imidazopyridedine derivatives | |
GB9508536D0 (en) | Quinazoline derivative | |
GB9508566D0 (en) | Quinazoline derivative | |
GB9508568D0 (en) | Quinazoline derivative | |
GB9508567D0 (en) | Quinazoline derivative | |
GB9700695D0 (en) | Quinazoline derivatives | |
GB9603049D0 (en) | Quinazoline derivatives | |
GB9606865D0 (en) | Quinazoline derivatives |